SCHEMBL19924196

SCHEMBL19924196

CCCCC(C)(CNC(C)=O)Nc1nc(NCc2ccc(OC)cc2OC)nc2cnccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 1/20 0.43
▸ CYP1A2 P05177 8/20 0.41
▸ CYP3A4 P08684 8/20 0.41
▸ CYP2C19 P33261 7/20 0.41
▸ CYP2D6 P10635 7/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ HSD17B10 Q99714 5/20 0.41
▸ TSHR P16473 5/20 0.41
▸ CYP2C9 P11712 4/20 0.41
▸ LMNA P02545 4/20 0.41
▸ USP2 O75604 4/20 0.41
▸ FLT3 P36888 1/20 0.40
▸ TYRO3 Q06418 1/20 0.40
▸ MERTK Q12866 1/20 0.40
▸ GAS6 Q14393 1/20 0.40
▸ CLK1 P49759 1/20 0.39
▸ CLK2 P49760 1/20 0.39
▸ CLK3 P49761 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924194 1.00 KDM4C (0.43) KDM4CCYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL19924221 0.90 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL19924222 0.90 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL19924272 0.88 TSHR (0.40) CYP1A2CYP3A4CYP2C19CYP2D6HSD17B10
SCHEMBL30076198 0.88 TSHR (0.40) CYP1A2CYP3A4CYP2C19CYP2D6HSD17B10
SCHEMBL19924273 0.88 TSHR (0.40) CYP1A2CYP3A4CYP2C19CYP2D6HSD17B10
SCHEMBL19924184 0.87 FLT3 (0.39) KDM4CCYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL30076215 0.87 FLT3 (0.39) KDM4CCYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL19924186 0.87 FLT3 (0.39) KDM4CCYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL19991832 0.85 FLT3 (0.42) KDM4CCYP1A2CYP3A4CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12522570-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2026-01-13 — — US disclosed
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2024-08-01 — — US disclosed
US-11827609-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2023-11-28 — — US disclosed
US-20220073473-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2022-03-10 — — US disclosed
EP-3507276-B1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-11-03 — — EP disclosed
EP-3507276-B1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-11-03 — — EP disclosed
US-11124487-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2021-09-21 — — US disclosed
US-11124487-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2021-09-21 — — US disclosed
US-10370342-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2019-08-06 — — US disclosed
US-10370342-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2019-08-06 — — US disclosed
WO-2018045144-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2018-03-08 — — WO disclosed
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2018-03-08 — — US disclosed
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073473-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885
US-10370342-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885
US-11124487-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885
US-11827609-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KDM4C 3882/4885CYP1A2 4638/4885CYP3A4 4333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback